Import Biopaper — Buy in Bulk from Supplier in China

Beijing Datsing Bio-tech Co., Ltd. supplies Biopaper, a biodegradable hemostatic material constructed from two natural polysaccharides for wound management and bleeding control. The material promotes blood clotting for minor to moderate wounds and is supplied in sterile packaging to maintain aseptic conditions during application. The polysaccharide composition ensures complete biodegradability, eliminating the need for removal from the wound bed and reducing patient trauma during dressing changes. The lightweight physical form factor supports use in first aid kits, field hospitals, and emergency medical services where rapid deployment is critical.

The dual-polysaccharide matrix typically combines chitosan and cellulose derivatives, though the exact formulation ratio should be confirmed with the supplier. Standard hemostatic grades in this category achieve clotting initiation within 1-3 minutes of application to bleeding surfaces, with full biodegradation occurring within 14-21 days depending on wound environment and patient physiology. The material conforms to wound topography without requiring pressure application beyond initial placement, distinguishing it from granular hemostats that require sustained compression. Sterility assurance level (SAL) typically meets 10^-6 for terminal sterilization, standard for Class II medical devices in wound care applications.

Healthcare procurement teams, emergency services supply officers, and military medical quartermasters represent the primary buyers for this material. Applications span pre-hospital trauma care, surgical hemostasis in resource-limited settings, disaster response kits, and veterinary emergency practices. Buyers should confirm the exact polysaccharide composition, biodegradation timeline under ISO 10993-6 implantation testing, and whether the sterile barrier packaging meets ISO 11607 requirements for shelf-life validation. The supplier lists L/C and T/T as available payment instruments, though specific commercial terms require direct negotiation.

Beijing Datsing Bio-tech Co., Ltd. maintains its registered address at Room C701, No. 9 3rd Street, Haidian District, Beijing 100085, placing the operation within Beijing's established biotechnology and research corridor. The supplier carries an imported tier classification and a harbor trust tier designation, with a recorded response rate of 0.00% and zero average response hours in the available data. These response metrics suggest either a newly listed profile, a dormant account, or a data capture anomaly that prospective buyers should verify through direct outreach before relying on platform-recorded availability.

The company profile does not disclose manufacturing facility details, employee count, annual revenue, client references, or specific quality management system certifications beyond the product-level claims. No information is provided about production capacity, batch consistency protocols, or custom formulation capabilities. Buyers should request the supplier's ISO 13485 certificate, biocompatibility test reports per ISO 10993, and sterility validation data before committing to procurement. The absence of verified response history means due diligence on supplier operational status is particularly important for time-sensitive medical supply needs.